Heerlen, NL, 15 Sep 2015 18:15 CEST
Royal DSM, the global Life Science and Materials Sciences company, has successfully issued a €500 million 1.375% bond due 2022.
The proceeds will be used for general purposes.
The terms are laid down in the €4 billion Debt Issuance Program of Royal DSM, the final terms and the supplements thereto.
The re-offer price was 99.841%. Based on this price the yield is 1.399%. The bond will be listed on Euronext Amsterdam shortly.
This release does not constitute an offer or an invitation to subscribe for or purchase any securities. The notes are being offered only by means of a prospectus.